SEC Filing Details
Document Details
Form
Filing Date
February 17, 2026
Document Date
February 12, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Collins Helen Louise